QSC PHARMA GRADE
🇮🇳 India Warehouse100-Count Pack
What is Brilinta 90mg (1X180) (TICAGRELOR)?
P2Y12 antiplatelet agent for acute coronary syndrome (ACS) and post-MI prevention. Faster, more potent, more consistent platelet inhibition than clopidogrel — reduces mortality after heart attack.
How it Works
Direct-acting reversible P2Y12 ADP receptor antagonist — no metabolic activation required unlike clopidogrel. More predictable and potent antiplatelet effect.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | TICAGRELOR |
| Dose per Tablet | 90MG |
| Pack Size | 10×10 (100 tablets) |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Dyspnea (unique to ticagrelor — usually mild, not cardiac), bleeding, bradyarrhythmia (transient), elevated uric acid.
Safety Warnings
⚠️ Dyspnea: evaluate for cardiac/pulmonary causes but may be drug effect (usually resolves). Avoid strong CYP3A4 inhibitors/inducers. High bleeding risk especially GI. Do NOT use high-dose aspirin with ticagrelor.

